Statistics for Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment

Total visits

views
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment 0

Total visits per month

views
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 0
January 2026 0
February 2026 0